Marc Umscheid - Net Worth and Insider Trading
Marc Umscheid Net Worth
The estimated net worth of Marc Umscheid is at least $77 dollars as of 2024-06-01. Marc Umscheid is the Chief Strategy/Mkt Officer of Sonoma Pharmaceuticals Inc and owns about 377 shares of Sonoma Pharmaceuticals Inc (SNOA) stock worth over $77. Details can be seen in Marc Umscheid's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Marc Umscheid has not made any transactions after 2017-08-10 and currently still holds the listed stock(s).
Transaction Summary of Marc Umscheid
Marc Umscheid Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marc Umscheid owns 1 companies in total, including Sonoma Pharmaceuticals Inc (SNOA) .
Click here to see the complete history of Marc Umscheid’s form 4 insider trades.
Insider Ownership Summary of Marc Umscheid
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals Inc | 2017-08-10 | Chief Strategy/Mkt Officer |
Marc Umscheid Latest Holdings Summary
Marc Umscheid currently owns a total of 1 stock. Marc Umscheid owns 377 shares of Sonoma Pharmaceuticals Inc (SNOA) as of August 10, 2017, with a value of $77.
Latest Holdings of Marc Umscheid
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals Inc | 2017-08-10 | 377 | 0.20 | 77 |
Holding Weightings of Marc Umscheid
Marc Umscheid Form 4 Trading Tracker
According to the SEC Form 4 filings, Marc Umscheid has made a total of 0 transactions in Sonoma Pharmaceuticals Inc (SNOA) over the past 5 years. The most-recent trade in Sonoma Pharmaceuticals Inc is the acquisition of 67 shares on August 10, 2017, which cost Marc Umscheid around $3,186.
Insider Trading History of Marc Umscheid
- 1
Marc Umscheid Trading Performance
GuruFocus tracks the stock performance after each of Marc Umscheid's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marc Umscheid is -4%. GuruFocus also compares Marc Umscheid's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marc Umscheid within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Marc Umscheid's insider trading performs compared to the benchmark.
Performance of Marc Umscheid
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.97 | | | | | |
| Relative Return to S&P 500(%) | 2.87 | | | | | |
Marc Umscheid Ownership Network
Marc Umscheid Owned Company Details
What does Sonoma Pharmaceuticals Inc do?
Who are the key executives at Sonoma Pharmaceuticals Inc?
Marc Umscheid is the Chief Strategy/Mkt Officer of Sonoma Pharmaceuticals Inc. Other key executives at Sonoma Pharmaceuticals Inc include Interim CFO Chad Norman White , Chief Financial Officer Jerome J Dvonch , and Chief Financial Officer Robert Grant Edwards .
Sonoma Pharmaceuticals Inc (SNOA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sonoma Pharmaceuticals Inc (SNOA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonoma Pharmaceuticals Inc (SNOA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sonoma Pharmaceuticals Inc (SNOA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonoma Pharmaceuticals Inc Insider Transactions
Marc Umscheid Mailing Address
Above is the net worth, insider trading, and ownership report for Marc Umscheid. You might contact Marc Umscheid via mailing address: Oculus Innovative Sciences, Inc., 1129 N. Mcdowell Blvd., Petaluma Ca 94954.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
